Navigation Links
Global Personalized Medicine and Companion Diagnostic Market Q2 2013 - A Strategic Analysis of Industry Trends, Technologies, Participants and Environment Research Report
Date:7/23/2013

Albany, NY (PRWEB) July 24, 2013

This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by 261 tables & figures over 205 pages. The personalized medicine (global) market is presented as follows:

By Company (e.g., 23andMe, AFFYMETRIX, ATOSSA GENETICS, NODALITY, decode /Amgen, CELERA, MYRIAD)
By Geography (US, UK, EU)
By Segment (Targeted Therapeutics, Companion Diagnostics, Esoteric tests, Esoteric lab services)
By Sub-market (Companion diagnostics & therapeutic, nutrition & wellness, medical technology, Pharmacogenomics, consumer genomics)

To check out the Complete table of contents, visit: http://www.marketresearchreports.biz/analysis-details/personalized-medicine-and-companion-diagnostic-market-q2-2013-a-strategic-analysis-of-industry-trends-technologies-participants-and-environment

A wealth of financial data & business strategy information is provided including:

    Up-to-date company Financials, sales & revenue figures
    Business Model Strategies for Diagnostic, Pharmaceutical and Biotechnology Companies
    Business Model Strategies for Providers. Provider Systems and Academic Medical Centers
    Business Model Strategies for Payers & Governments
    Private and Public Funding and Personalized Medicine Reimbursement
    Revisions to Current Payment Systems and intellectual property
    How to Gain Market Penetration in the EU
    Cost-effectiveness and Business Value of Personalized Medicine
    Consumer genomics and POC market
    Therapeutics and Companion Diagnostics (e.g., BRAC Analysis, Oncotype Dx , KRAS Mutations)
    Comprehensive account of company product portfolios & kits

Browse All The Report Of This Publisher, Visit: http://www.marketresearchreports.biz/publisher/96

SWOT, Economic & Regulatory Environment specifics include:

    Key strengths, weaknesses and threats influencing leading player position within the market
    Technologies driving the market (e.g., New-Generation Sequencing Technologies, Ultra-High Throughput Sequencing)
    Top fastest growing market segments and emerging opportunities
    Top pharmaceutical companies within the IPM by market share and revenue
    Comprehensive product portfolios, R&D activity and pipeline therapeutics
    M&A activity and future strategies of top personalized medicine pharmacies
    Personalized Medicine Regulation (UK, Germany, France, Spain, Italy)
    CE-marked Personalized Medicine/Diagnostic Tests
    FDA Advances in Personalized Medicine Regulation

For more reports of this category, Visit - http://www.marketresearchreports.biz/category/38

This report highlights a number of significant Indian pharmacy and gives details of their operations, products, financial and business strategy.

    23andMe
    Affymetrix
    Astex Pharmaceuticals
    Atossa Genetics
    CuraGen
    Celera Corporation (Quest Diagnostics)
    Celldex Therapeutics
    Decode Genetics (Amgen)
    Illumine
    Genelex
    Myriad
    Nodality
    Qiagen

For Premium Market Research Reports, Visit - http://mresearchreports.blogspot.com/

What you will gain:

An in-depth understanding of the global personalized medicine market and its environment
Current market facts, figures and product lines of key players in the industry
Emerging trends in key markets such as the US, UK, Germany and France
Knowledge of how the personalized medicine market will integrate into the global healthcare market
Technical insights into a new generation sequencing technologies and ultra-high throughput sequencing
Updates on Bioinformatics, high throughput systems, genetic analysis kits, companion diagnostics and future technologies
FDA approved pharmacogenetic tests and recognized biomarkers
Information on key government and regulatory policies
Strategies on how to adapt and restructure current business models in this industry

This report tackles key concerns to the personalized medicine market such as:

    Lack of regulatory policy and legislation in the US and Europe
    Reimbursement schemes and payers concerns
    Transition of investigational diagnostic assays and therapeutics to clinical practice
    Direct to consumer (DTC) test kits and implications for the public

To Buy The Copy of This Report, Visit: http://www.marketresearchreports.biz/analysis/171740

Who should read this report?

Pharmaceutical, biotechnology and diagnostic companies with an interest in personalized medicine
Industry professionals and business strategists will discover key information to propel their policies
Investors will gain inside information to dominant players in the industry and future forecasts
Scientists will get a business perspective and industry insight into how scientific breakthroughs influence the market environment

This report will tell you if the companies mentioned are:

    Strong, competitive players
    Pooling their resources for specific growth and therapeutic areas
    Investing strategically in R&D
    Have a history of strategic M&A activity

Contact US
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Email: sales(at)marketresearchreports(dot)biz
Website: http://www.marketresearchreports.biz/
Blog: http://mrrbiz.blogspot.com/    
Blog: http://marketsbuzz.wordpress.com/

Read the full story at http://www.prweb.com/releases/2013/Personalized-Medicine/prweb10954759.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Gianluca Tognon Announces a New E-book About the Consequences of Global Warming on Food Safety and Human Health
2. Radiofrequency Ablation Devices Market is Expected to Reach USD 1.0 Billion Globally in 2018: Transparency Market Research
3. Global Portable Oxygen Concentrators Market are Anticipated to Reach $1.9 billion by 2019 - Industry Shares, Strategies, and Forecasts, Worldwide Research Report
4. Health Affairs July issue contains global innovation studies from India And Brazil
5. Global Digital Pathology Market to Reach $336.6 Million by 2017 at a CAGR of 12% - New Report by MarketsandMarkets
6. Global Cardiac Bio Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent)
7. Global Ammunition Market Worth $8.15 Billion by 2017 at a CAGR of 0.67% - New Report by MarketsandMarkets
8. Global Magnetic Resonance Imaging System Market – MRI 2018 Forecast & Analysis in New Research Report at ReportsnReports.com
9. Global Catheters Market Will Reach USD 33.3 Billion in 2017: Transparency Market Research
10. Global Food Protection Institute to Exhibit at Institute of Food Technologists' Food Expo
11. j2 Global’s Annual Mid-Year Small Business Report Card: How SMBs Get Work Done
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and employees in ... come courtesy of leaders in the nursing and health care industry. It also provides ... associations—namely Abilene Christian University. , As the nursing industry is coming out of ...
(Date:5/26/2016)... ... ... Despite last week’s media reports hinting at a June rate hike after the Federal ... an interest rate increase, according to Rajeev Dhawan of the Economic Forecasting Center at ... Committee (FOMC) dot charts are of interest to the press for their noise potential,” ...
(Date:5/26/2016)... California (PRWEB) , ... May 26, 2016 , ... ... associated with discovery of thousands of defective respirators, according to court documents and ... the case of William and Becky Tyler v. American Optical Corporation, Case No. ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, through ... a partner for the Tamika Catchings Legacy Tour that will commemorate the ... in hardwood basketball surfaces in all forms and levels of the game, Connor Sports ...
(Date:5/26/2016)... PA (PRWEB) , ... May 26, 2016 , ... ... and one that has a significant negative impact on long-term patient survival, reports ... date. The results, published online this week in the Journal of Thoracic and ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... 27, 2016 Amarantus BioScience Holdings, Inc. ... products for Regenerative Medicine, Neurology and Orphan Diseases, today announced that ... at two upcoming investor conferences: SeeThru Equity MicroCap ... New York City , NY When: ... Marcum MicroCap Conference   Where: Grand Hyatt Hotel, 109 ...
(Date:5/26/2016)... May 26, 2016   Change Healthcare ... analytics, network solutions and technology-enabled services designed ... entered into a strategic channel partnership with ... software solutions and revenue cycle management services ... and rehabilitation clinics to optimize revenue, operational ...
(Date:5/25/2016)... and GERMANTOWN, Maryland , May 25, 2016 ... ; Frankfurt Prime Standard: QIA) today announced that the company ... Diagnostics GmbH to develop and commercialize predictive assays in oncology. ... as a marker to predict effectiveness of anthracycline treatment in ... "We are pleased to partner with Therawis, which developed the ...
Breaking Medicine Technology: